Putnam Investments LLC Ascendis Pharma A/S Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Putnam Investments LLC holds 725,651 shares of ASND stock, worth $92.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

725,651

Previous 772,362 6.05%

Holding current value

$92.6 Million

Previous $72.3 Million 26.37%

% of portfolio

0.13%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $4.02 Million - $5.95 Million	-46,711 Reduced 6.05%	725,651 $91.4 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $11 Million - $13.3 Million	-127,470 Reduced 14.17%	772,362 $72.3 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $11.1 Million - $15.6 Million	158,970 Added 21.46%	899,832 $80.3 Million
Q1 2023 May 22, 2023	BUY	$104.9 - $126.78 $3.61 Million - $4.37 Million	34,453 Added 4.88%	740,862 $79.4 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $8.12 Million - $10.8 Million	-81,656 Reduced 10.36%	706,409 $86.3 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $1.33 Million - $1.75 Million	-15,846 Reduced 1.97%	788,065 $81.4 Million
Q2 2022 Aug 15, 2022	BUY	$78.08 - $117.61 $13.4 Million - $20.2 Million	171,742 Added 27.17%	803,911 $74.7 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $13.4 Million - $17.8 Million	131,054 Added 26.15%	632,169 $74.2 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $5.99 Million - $8 Million	47,154 Added 10.39%	501,115 $67.4 Million
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $3.66 Million - $5.75 Million	32,488 Added 7.71%	453,961 $72.4 Million
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $39 Million - $46.6 Million	320,657 Added 318.06%	421,473 $55.4 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $13.7 Million - $19 Million	-109,863 Reduced 52.15%	100,816 $13 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $27.1 Million - $32.8 Million	-179,408 Reduced 45.99%	210,679 $35.1 Million
Q3 2020 Nov 16, 2020	SELL	$134.29 - $154.32 $25.8 Million - $29.6 Million	-191,921 Reduced 32.98%	390,087 $60.2 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $1.46 Million - $2.05 Million	13,137 Added 2.31%	582,008 $86.1 Million
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $38.3 Million - $57.3 Million	394,924 Added 227.04%	568,871 $64.1 Million
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $105,258 - $160,127	1,151 Added 0.67%	173,947 $24.2 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $7.27 Million - $9.03 Million	-75,920 Reduced 30.52%	172,796 $16.6 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $8.66 Million - $10.7 Million	80,805 Added 48.12%	248,716 $28.6 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $550,338 - $1.15 Million	8,855 Added 5.57%	167,911 $19.8 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $298,250 - $376,705	-5,407 Reduced 3.29%	159,056 $9.97 Million
Q3 2018 Nov 14, 2018	BUY	$63.77 - $76.28 $10.5 Million - $12.5 Million	164,463 New	164,463 $11.7 Million

Others Institutions Holding ASND

# of Institutions

228

Shares Held

56.6M

Call Options Held

125K

Put Options Held

239K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.13B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Ascendis Pharma A/S Transaction History